Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma

References

• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2019. [cited 2020 Jan 27]. Available from: http://ginasthma.org/gina-reports/
   Google Scholar
• Chen S, Golam S, Myers J, et al. Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment. Curr Med Res Opin. 2018;34(12):2075–2088.
   PubMed Web of Science ®Google Scholar
• Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180(5):388–395.
   PubMed Web of Science ®Google Scholar
• McDowell PJ, Heaney LG. Different endotypes and phenotypes drive the heterogeneity in severe asthma. Allergy. 2020;75(2):302–310.
   PubMed Web of Science ®Google Scholar
• Tran TN, Zeiger RS, Peters SP, et al. Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma. Ann Allergy Asthma Immunol. 2016;116(1):37–42.
   PubMed Web of Science ®Google Scholar
• Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716–725.
   PubMed Web of Science ®Google Scholar
• Carr TF, Zeki AA, Kraft M. Eosinophilic and noneosinophilic asthma. Am J Respir Crit Care Med. 2018;197(1):22–37.
   PubMed Web of Science ®Google Scholar
• Tliba O, Panettieri RA Jr. Paucigranulocytic asthma: uncoupling of airway obstruction from inflammation. J Allergy Clin Immunol. 2019;143(4):1287–1294.
   PubMed Web of Science ®Google Scholar
• Moore WC, Hastie AT, Li X, et al. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol. 2014;133(6):1557–1563.
   PubMed Web of Science ®Google Scholar
• Normansell R, Walker S, Milan SJ, et al. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev. 2014;1:CD003559.
   PubMed Web of Science ®Google Scholar
• Farne HA, Wilson A, Powell C, et al. Anti-IL5 therapies for asthma. Cochrane Database Syst Rev. 2017;9:CD010834.
   PubMed Web of Science ®Google Scholar
• Zayed Y, Kheiri B, Banifadel M, et al. Dupilumab safety and efficacy in uncontrolled asthma: a systematic review and meta-analysis of randomized clinical trials. J Asthma. 2019;56(10):1110–1119.
   PubMed Web of Science ®Google Scholar
• Castro M, Corren J, Pavord ID, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378(26):2486–2496.
   PubMed Web of Science ®Google Scholar
• Hanania NA, Wenzel S, Rosen K, et al. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med. 2013;187(8):804–811.
   PubMed Web of Science ®Google Scholar
• Mitchell PD, O’Byrne PM. Epithelial-derived cytokines in asthma. CHEST. 2017;151(6):1338–1344.
   PubMed Web of Science ®Google Scholar
• Corren J, Ziegler SF. TSLP: from allergy to cancer. Nat Immunol. 2019;20(12):1603–1609.
   PubMed Web of Science ®Google Scholar
• Allakhverdi Z, Comeau MR, Jessup HK, et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med. 2007;204(2):253–258.
   PubMed Web of Science ®Google Scholar
• Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3(7):673–680.
   PubMed Web of Science ®Google Scholar
• Kitajima M, Lee HC, Nakayama T, et al. TSLP enhances the function of helper type 2 cells. Eur J Immunol. 2011;41(7):1862–1871.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhou B. Functions of thymic stromal lymphopoietin in immunity and disease. Immunol Res. 2012;52(3):211–223.
   PubMed Web of Science ®Google Scholar
• Ziegler SF, Roan F, Bell BD, et al. The biology of thymic stromal lymphopoietin (TSLP). Adv Pharmacol. 2013;66:129–155.
   PubMedGoogle Scholar
• Ferreira DS, Annoni R, Silva LF, et al. Toll-like receptors 2, 3 and 4 and thymic stromal lymphopoietin expression in fatal asthma. Clin Exp Allergy. 2012;42(10):1459–1471.
   PubMed Web of Science ®Google Scholar
• Kaur D, Doe C, Woodman L, et al. Mast cell-airway smooth muscle crosstalk: the role of thymic stromal lymphopoietin. CHEST. 2012;142(1):76–85.
   PubMed Web of Science ®Google Scholar
• Shikotra A, Choy DF, Ohri CM, et al. Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma. J Allergy Clin Immunol. 2012;129(1):104–111.
   PubMed Web of Science ®Google Scholar
• Bleck B, Kazeros A, Bakal K, et al. Coexpression of type 2 immune targets in sputum-derived epithelial and dendritic cells from asthmatic subjects. J Allergy Clin Immunol. 2015;136(3):619–627 e615.
   PubMed Web of Science ®Google Scholar
• Lee TJ, Fu CH, Wang CH, et al. Impact of chronic rhinosinusitis on severe asthma patients. PLoS One. 2017;12(2):e0171047.
   PubMed Web of Science ®Google Scholar
• Al-Sajee D, Sehmi R, Hawke TJ, et al. Expression of IL-33 and TSLP and their receptors in asthmatic airways after inhaled allergen challenge. Am J Respir Crit Care Med. 2018;198(6):805–807.
   PubMed Web of Science ®Google Scholar
• Ying S, O’Connor B, Ratoff J, et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol. 2005;174(12):8183–8190.
   PubMed Web of Science ®Google Scholar
• Ying S, O’Connor B, Ratoff J, et al. Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol. 2008;181(4):2790–2798.
   PubMed Web of Science ®Google Scholar
• Chai R, Liu B, Qi F. The significance of the levels of IL-4, IL-31 and TLSP in patients with asthma and/or rhinitis. Immunotherapy. 2017;9(4):331–337.
   PubMed Web of Science ®Google Scholar
• Chauhan A, Singh M, Agarwal A, et al. Correlation of TSLP, IL-33, and CD4 + CD25 + FOXP3 + T regulatory (Treg) in pediatric asthma. J Asthma. 2015;52(9):868–872.
   PubMed Web of Science ®Google Scholar
• Berraies A, Hamdi B, Ammar J, et al. Increased expression of thymic stromal lymphopoietin in induced sputum from asthmatic children. Immunol Lett. 2016;178:85–91.
   PubMed Web of Science ®Google Scholar
• Gluck J, Rymarczyk B, Kasprzak M, et al. Increased levels of interleukin-33 and thymic stromal lymphopoietin in exhaled breath condensate in chronic bronchial asthma. Int Arch Allergy Immunol. 2016;169(1):51–56.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang W, Lv Z, et al. Elevated expression of IL-33 and TSLP in the airways of human asthmatics in vivo: A apotential biomarker of severe refractory disease. J Immunol. 2018;200(7):2253–2262.
   PubMed Web of Science ®Google Scholar
• Bjerregaard A, Laing IA, Poulsen N, et al. Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults. Respir Med. 2017;123:34–41.
   PubMed Web of Science ®Google Scholar
• West EE, Kashyap M, Leonard WJ. TSLP: a key regulator of asthma pathogenesis. Drug Discov Today Dis Mech. 2012;9:3–4.
   Google Scholar
• Moffatt MF, Gut IG, Demenais F, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2010;363(13):1211–1221.
   PubMed Web of Science ®Google Scholar
• Torgerson DG, Ampleford EJ, Chiu GY, et al. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet. 2011;43(9):887–892.
   PubMed Web of Science ®Google Scholar
• Hirota T, Takahashi A, Kubo M, et al. Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet. 2011;43(9):893–896.
   PubMed Web of Science ®Google Scholar
• He JQ, Hallstrand TS, Knight D, et al. A thymic stromal lymphopoietin gene variant is associated with asthma and airway hyperresponsiveness. J Allergy Clin Immunol. 2009;124(2):222–229.
   PubMed Web of Science ®Google Scholar
• Hunninghake GM, Soto-Quiros ME, Avila L, et al. TSLP polymorphisms are associated with asthma in a sex-specific fashion. Allergy. 2010;65(12):1566–1575.
   PubMed Web of Science ®Google Scholar
• Hui CC, Yu A, Heroux D, et al. Thymic stromal lymphopoietin (TSLP) secretion from human nasal epithelium is a function of TSLP genotype. Mucosal Immunol. 2015;8(5):993–999.
   PubMed Web of Science ®Google Scholar
• Moorehead A, Hanna R, Heroux D, et al., A thymic stromal lymphopoietin polymorphism may provide protection from asthma by altering gene expression. Clin Exp Allergy. 2020;50(4):471–478.
   PubMed Web of Science ®Google Scholar
• Buchheit KM, Cahill KN, Katz HR, et al. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137(5):1566–1576 e1565.
   PubMed Web of Science ®Google Scholar
• Gauvreau GM, O’Byrne PM, Boulet LP, et al., Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med. 2014;370(22): 2102–2110.
   PubMed Web of Science ®Google Scholar
• Corren J, Parnes J, Wang L, et al., Tezepelumab in adults with uncontrolled asthma. N Engl J Med. 2017;377(10):936–946.
   PubMed Web of Science ®Google Scholar
• Aun MV, Bonamichi-Santos R, Arantes-Costa FM, et al. Animal models of asthma: utility and limitations. J Asthma Allergy. 2017;10:293–301.
   PubMed Web of Science ®Google Scholar
• Sagar S, Akbarshahi H, Uller L. Translational value of animal models of asthma: challenges and promises. Eur J Pharmacol. 2015;759:272–277.
   PubMed Web of Science ®Google Scholar
• Semlali A, Jacques E, Koussih L, et al. Thymic stromal lymphopoietin-induced human asthmatic airway epithelial cell proliferation through an IL-13-dependent pathway. J Allergy Clin Immunol. 2010;125(4):844–850.
   PubMed Web of Science ®Google Scholar
• Uller L, Leino M, Bedke N, et al. Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-beta in bronchial epithelial cells from donors with asthma. Thorax. 2010;65(7):626–632.
   PubMed Web of Science ®Google Scholar
• Hardyman MA, Wilkinson E, Martin E, et al. TNF-alpha-mediated bronchial barrier disruption and regulation by src-family kinase activation. J Allergy Clin Immunol. 2013;132(3):665–675 e668.
   PubMed Web of Science ®Google Scholar
• Hui CC, Murphy DM, Neighbour H, et al. T cell-mediated induction of thymic stromal lymphopoietin in differentiated human primary bronchial epithelial cells. Clin Exp Allergy. 2014;44(7):953–964.
   PubMed Web of Science ®Google Scholar
• Weng CM, Wang CH, Lee MJ, et al. Aryl hydrocarbon receptor activation by diesel exhaust particles mediates epithelium-derived cytokines expression in severe allergic asthma. Allergy. 2018;73(11):2192–2204.
   PubMed Web of Science ®Google Scholar
• Kato A, Favoreto S Jr., Avila PC, et al. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol. 2007;179(2):1080–1087.
   PubMed Web of Science ®Google Scholar
• Zhu C, Lei W, Huang J. Azithromycin inhibits double-stranded RNA-induced thymic stromal lymphopoietin release from human airway epithelial cells. Pharmazie. 2013;68(11):899–903.
   PubMed Web of Science ®Google Scholar
• Jia X, Zhang H, Cao X, et al. Activation of TRPV1 mediates thymic stromal lymphopoietin release via the Ca2+/NFAT pathway in airway epithelial cells. FEBS Lett. 2014;588(17):3047–3054.
   PubMed Web of Science ®Google Scholar
• Paplinska-Goryca M, Nejman-Gryz P, Proboszcz M, et al. The effect of 1,25-dihydroxyvitamin D3 on TSLP, IL-33 and IL-25 expression in respiratory epithelium. Eur Cytokine Netw. 2016;27(2):54–62.
   PubMed Web of Science ®Google Scholar
• Hu Y, Dong H, Zou M, et al. TSLP signaling blocking alleviates E-cadherin dysfunction of airway epithelium in a HDM-induced asthma model. Cell Immunol. 2017;315:56–63.
   PubMed Web of Science ®Google Scholar
• Ni G, Chen Y, Wu F, et al. NOD2 promotes cell proliferation and inflammatory response by mediating expression of TSLP in human airway smooth muscle cells. Cell Immunol. 2017;312:35–41.
   PubMed Web of Science ®Google Scholar
• Dong H, Hu Y, Liu L, et al. Distinct roles of short and long thymic stromal lymphopoietin isoforms in house dust mite-induced asthmatic airway epithelial barrier disruption. Sci Rep. 2016;6:39559.
   PubMed Web of Science ®Google Scholar
• Brusselle G, Bracke K. Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(Suppl 5):S322–328.
   PubMedGoogle Scholar
• Walker JA, McKenzie AN. Development and function of group 2 innate lymphoid cells. Curr Opin Immunol. 2013;25(2):148–155.
   PubMed Web of Science ®Google Scholar
• Klose CS, Artis D. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat Immunol. 2016;17(7):765–774.
   PubMed Web of Science ®Google Scholar
• Bartemes KR, Kephart GM, Fox SJ, et al. Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol. 2014;134(3):671–678 e674.
   PubMed Web of Science ®Google Scholar
• Camelo A, Rosignoli G, Ohne Y, et al. IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells. Blood Adv. 2017;1(10):577–589.
   PubMed Web of Science ®Google Scholar
• Chen R, Smith SG, Salter B, et al. Allergen-induced increases in sputum levels of group 2 innate lymphoid cells in subjects with asthma. Am J Respir Crit Care Med. 2017;196(6):700–712.
   PubMed Web of Science ®Google Scholar
• Smith SG, Chen R, Kjarsgaard M, et al. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J Allergy Clin Immunol. 2016;137(1):75–86 e78.
   PubMed Web of Science ®Google Scholar
• Christianson CA, Goplen NP, Zafar I, et al. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J Allergy Clin Immunol. 2015;136(1):59–68 e14.
   PubMed Web of Science ®Google Scholar
• Yu QN, Guo YB, Li X, et al. ILC2 frequency and activity are inhibited by glucocorticoid treatment via STAT pathway in patients with asthma. Allergy. 2018;73(9):1860–1870.
   PubMed Web of Science ®Google Scholar
• Liu S, Verma M, Michalec L, et al., Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin. J Allergy Clin Immunol. 2018;141(1): 257–268 e256.
   PubMed Web of Science ®Google Scholar
• Sirohi K, Verma M, Michalec L, et al. Identification of MEK2 and CBX7 as top steroid resistant genes in airway ILC2s and lymphocytes from asthma. J Allergy Clin Immunol. 2018;141(2):AB1.
   Web of Science ®Google Scholar
• Hui CC, Rusta-Sallehy S, Asher I, et al. The effects of thymic stromal lymphopoietin and IL-3 on human eosinophil-basophil lineage commitment: relevance to atopic sensitization. Immun Inflamm Dis. 2014;2(1):44–55.
   PubMedGoogle Scholar
• Salter BMA, Smith SG, Mukherjee M, et al., Human bronchial epithelial cell-derived factors from severe asthmatic subjects stimulate eosinophil differentiation. Am J Respir Cell Mol Biol. <yr>2018</yr>;58(1): 99–106.
   PubMed Web of Science ®Google Scholar
• Smith SG, Gugilla A, Mukherjee M, et al. Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma. J Allergy Clin Immunol. 2015;135(6):1594–1602.
   PubMed Web of Science ®Google Scholar
• Allakhverdi Z, Comeau MR, Smith DE, et al. CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. J Allergy Clin Immunol. 2009;123(2):472–478.
   PubMed Web of Science ®Google Scholar
• Leuppi JD, Salome CM, Jenkins CR, et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med. 2001;163(2):406–412.
   PubMed Web of Science ®Google Scholar
• van Veen IH, Ten Brinke A, Gauw SA, et al. Consistency of sputum eosinophilia in difficult-to-treat asthma: a 5-year follow-up study. J Allergy Clin Immunol. 2009;124(3):615–617,
   PubMed Web of Science ®Google Scholar
• Lemiere C, Ernst P, Olivenstein R, et al. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol. 2006;118(5):1033–1039.
   PubMed Web of Science ®Google Scholar
• Wong CK, Hu S, Cheung PF, et al. Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation. Am J Respir Cell Mol Biol. 2010;43(3):305–315.
   PubMed Web of Science ®Google Scholar
• Cook EB, Stahl JL, Schwantes EA, et al. IL-3 and TNFalpha increase thymic stromal lymphopoietin receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation. Clin Mol Allergy. 2012;10(1):8.
   PubMedGoogle Scholar
• Morshed M, Yousefi S, Stockle C, et al. Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps. Allergy. 2012;67(9):1127–1137.
   PubMed Web of Science ®Google Scholar
• Allakhverdi Z, Comeau MR, Armant M, et al. Mast cell-activated bone marrow mesenchymal stromal cells regulate proliferation and lineage commitment of CD34(+) progenitor cells. Front Immunol. 2013;4:461.
   PubMed Web of Science ®Google Scholar
• Siracusa MC, Saenz SA, Hill DA, et al. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature. 2011;477(7363):229–233.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Wright PW, Woodfolk JA. Allergen induces dual upregulation of TSLP receptor on circulating basophils and dendritic cells in atopic dermatitis. J Allergy Clin Immunol. 2012;129(2):AB69.
   Web of Science ®Google Scholar
• Agrawal R, Wisniewski J, Yu MD, et al. Infection with human rhinovirus 16 promotes enhanced IgE responsiveness in basophils of atopic asthmatics. Clin Exp Allergy. 2014;44(10):1266–1273.
   PubMed Web of Science ®Google Scholar
• Boita M, Heffler E, Omede P, et al. Basophil membrane expression of epithelial cytokine receptors in patients with severe asthma. Int Arch Allergy Immunol. 2018;175(3):171–176.
   PubMed Web of Science ®Google Scholar
• Salter BM, Oliveria JP, Nusca G, et al. Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent. J Allergy Clin Immunol. 2015;136(6):1636–1644.
   PubMed Web of Science ®Google Scholar
• Salter BM, Oliveria JP, Nusca G, et al. IL-25 and IL-33 induce Type 2 inflammation in basophils from subjects with allergic asthma. Respir Res. 2016;17:5.
   PubMed Web of Science ®Google Scholar
• Nagarkar DR, Poposki JA, Comeau MR, et al. Airway epithelial cells activate Th2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin. J Allergy Clin Immunol. 2012;130(1):225–232 e224.
   PubMed Web of Science ®Google Scholar
• Okayama Y, Okumura S, Sagara H, et al. FcepsilonRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells. Eur Respir J. 2009;34(2):425–435.
   PubMed Web of Science ®Google Scholar
• Moon PD, Kim HM. Thymic stromal lymphopoietin is expressed and produced by caspase-1/NF-kappaB pathway in mast cells. Cytokine. 2011;54(3):239–243.
   PubMed Web of Science ®Google Scholar
• Allakhverdi Z, Comeau MR, Jessup HK, et al. Thymic stromal lymphopoietin as a mediator of crosstalk between bronchial smooth muscles and mast cells. J Allergy Clin Immunol. 2009;123(4):958–960 e952.
   PubMed Web of Science ®Google Scholar
• Hirano R, Hasegawa S, Hashimoto K, et al. Human thymic stromal lymphopoietin enhances expression of CD80 in human CD14+ monocytes/macrophages. Inflamm Res. 2011;60(6):605–610.
   PubMed Web of Science ®Google Scholar
• Reche PA, Soumelis V, Gorman DM, et al. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol. 2001;167(1):336–343.
   PubMed Web of Science ®Google Scholar
• Hanabuchi S, Ito T, Park WR, et al. Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J Immunol. 2010;184(6):2999–3007.
   PubMed Web of Science ®Google Scholar
• Arima K, Watanabe N, Hanabuchi S, et al. Distinct signal codes generate dendritic cell functional plasticity. Sci Signal. 2010;3(105):ra4.
   PubMed Web of Science ®Google Scholar
• Ito T, Wang YH, Duramad O, et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med. 2005;202(9):1213–1223.
   PubMed Web of Science ®Google Scholar
• Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med. 2006;203(2):269–273.
   PubMed Web of Science ®Google Scholar
• Kashyap M, Rochman Y, Spolski R, et al. Thymic stromal lymphopoietin is produced by dendritic cells. J Immunol. 2011;187(3):1207–1211.
   PubMed Web of Science ®Google Scholar
• Elder MJ, Webster SJ, Williams DL, et al. TSLP production by dendritic cells is modulated by IL-1beta and components of the endoplasmic reticulum stress response. Eur J Immunol. 2016;46(2):455–463.
   PubMed Web of Science ®Google Scholar
• Watanabe N, Hanabuchi S, Soumelis V, et al. Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion. Nat Immunol. 2004;5(4):426–434.
   PubMed Web of Science ®Google Scholar
• Wang YH, Angkasekwinai P, Lu N, et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med. 2007;204(8):1837–1847.
   PubMed Web of Science ®Google Scholar
• Froidure A, Shen C, Gras D, et al. Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses. Allergy. 2014;69(8):1068–1076.
   PubMed Web of Science ®Google Scholar
• Huang L, Zhang X, Wang M, et al. Exosomes from thymic stromal lymphopoietin-activated dendritic cells promote Th2 differentiation through the OX40 ligand. Pathobiology. 2019;86(2–3):111–117.
   PubMed Web of Science ®Google Scholar
• Nguyen KD, Vanichsarn C, Nadeau KC. TSLP directly impairs pulmonary Treg function: association with aberrant tolerogenic immunity in asthmatic airway. Allergy Asthma Clin Immunol. 2010;6(1):4.
   PubMedGoogle Scholar
• Wang YH, Ito T, Wang YH, et al. Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity. 2006;24(6):827–838.
   PubMed Web of Science ®Google Scholar
• Rochman I, Watanabe N, Arima K, et al. Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4+ T cells. J Immunol. 2007;178(11):6720–6724.
   PubMed Web of Science ®Google Scholar
• Rochman Y, Dienger-Stambaugh K, Richgels PK, et al. TSLP signaling in CD4(+) T cells programs a pathogenic T helper 2 cell state. Sci Signal. 2018;11:521.
   Web of Science ®Google Scholar
• Akamatsu T, Watanabe N, Kido M, et al. Human TSLP directly enhances expansion of CD8+ T cells. Clin Exp Immunol. 2008;154(1):98–106.
   PubMed Web of Science ®Google Scholar
• Jones CE, Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol. 2002;26(6):748–753.
   PubMed Web of Science ®Google Scholar
• Chesne J, Braza F, Mahay G, et al. IL-17 in severe asthma. Where do we stand? Am J Respir Crit Care Med. 2014;190(10):1094–1101.
   PubMed Web of Science ®Google Scholar
• Tanaka J, Watanabe N, Kido M, et al. Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions. Clin Exp Allergy. 2009;39(1):89–100.
   PubMed Web of Science ®Google Scholar
• Liang Y, Yu B, Chen J, et al. Thymic stromal lymphopoietin epigenetically upregulates Fc receptor gamma subunit-related receptors on antigen-presenting cells and induces TH2/TH17 polarization through dectin-2. J Allergy Clin Immunol. 2019;144(4):1025–1035 e1027.
   PubMed Web of Science ®Google Scholar
• West EE, Spolski R, Kazemian M, et al. A TSLP-complement axis mediates neutrophil killing of methicillin-resistant Staphylococcus aureus. Sci Immunol. 2016;1(5):eaaf8471.
   PubMed Web of Science ®Google Scholar
• Wang W, Li Y, Lv Z, et al. Bronchial allergen challenge of patients with atopic asthma triggers an alarmin (IL-33, TSLP, and IL-25) response in the airways epithelium and submucosa. J Immunol. 2018;201(8):2221–2231.
   PubMed Web of Science ®Google Scholar
• Fehrenbach H, Wagner C, Wegmann M. Airway remodeling in asthma: what really matters. Cell Tissue Res. 2017;367(3):551–569.
   PubMed Web of Science ®Google Scholar
• Redhu NS, Gounni AS. Function and mechanisms of TSLP/TSLPR complex in asthma and COPD. Clin Exp Allergy. 2012;42(7):994–1005.
   PubMed Web of Science ®Google Scholar
• Smelter DF, Sathish V, Thompson MA, et al. Thymic stromal lymphopoietin in cigarette smoke-exposed human airway smooth muscle. J Immunol. 2010;185(5):3035–3040.
   PubMed Web of Science ®Google Scholar
• Shan L, Redhu NS, Saleh A, et al. Thymic stromal lymphopoietin receptor-mediated IL-6 and CC/CXC chemokines expression in human airway smooth muscle cells: role of MAPKs (ERK1/2, p38, and JNK) and STAT3 pathways. J Immunol. 2010;184(12):7134–7143.
   PubMed Web of Science ®Google Scholar
• Redhu NS, Shan L, Movassagh H, et al. Thymic stromal lymphopoietin induces migration in human airway smooth muscle cells. Sci Rep. 2013;3:2301.
   PubMed Web of Science ®Google Scholar
• Nino G, Huseni S, Perez GF, et al. Directional secretory response of double stranded RNA-induced thymic stromal lymphopoietin (TSLP) and CCL11/eotaxin-1 in human asthmatic airways. PLoS One. 2014;9(12):e115398.
   PubMed Web of Science ®Google Scholar
• Futamura K, Orihara K, Hashimoto N, et al. beta2-Adrenoceptor agonists enhance cytokine-induced release of thymic stromal lymphopoietin by lung tissue cells. Int Arch Allergy Immunol. 2010;152(4):353–361.
   PubMed Web of Science ®Google Scholar
• Redhu NS, Saleh A, Halayko AJ, et al. Essential role of NF-kappaB and AP-1 transcription factors in TNF-alpha-induced TSLP expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2011;300(3):L479–485.
   PubMed Web of Science ®Google Scholar
• Cao L, Liu F, Liu Y, et al., TSLP promotes asthmatic airway remodeling via p38-STAT3 signaling pathway in human lung fibroblast. Exp Lung Res. 2018;44(6):288–301.
   PubMed Web of Science ®Google Scholar
• Wu J, Liu F, Zhao J, et al. Thymic stromal lymphopoietin promotes asthmatic airway remodelling in human lung fibroblast cells through STAT3 signalling pathway. Cell Biochem Funct. 2013;31(6):496–503.
   PubMed Web of Science ®Google Scholar
• Li Y, Lund C, Nervik I, et al. Characterization of signaling pathways regulating the expression of pro-inflammatory long form thymic stromal lymphopoietin upon human metapneumovirus infection. Sci Rep. 2018;8(1):883.
   PubMed Web of Science ®Google Scholar
• Wieczfinska J, Pawliczak R. Thymic stromal lymphopoietin and apocynin alter the expression of airway remodeling factors in human rhinovirus-infected cells. Immunobiology. 2017;222(8–9):892–899.
   PubMed Web of Science ®Google Scholar
• Wu J, Dong F, Wang RA, et al. Central role of cellular senescence in TSLP-induced airway remodeling in asthma. PLoS One. 2013;8(10):e77795.
   PubMed Web of Science ®Google Scholar
• Birben E, Sahiner UM, Karaaslan C, et al. The genetic variants of thymic stromal lymphopoietin protein in children with asthma and allergic rhinitis. Int Arch Allergy Immunol. 2014;163(3):185–192.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. Single ascending doses study of anti-interleukin-7 receptor α monoclonal antibody (GSK2618960) in healthy volunteers [cited 2020 Jan 27]. Available from: https://clinicaltrials.gov/ct2/show/NCT02293161
   Google Scholar
• Ellis J, van Maurik A, Fortunato L, et al. Anti-IL-7 receptor alpha monoclonal antibody (GSK2618960) in healthy subjects - a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol. 2019;85(2):304–315.
   PubMed Web of Science ®Google Scholar
• Mukherjee M, Bulir DC, Radford K, et al. Sputum autoantibodies in patients with severe eosinophilic asthma. J Allergy Clin Immunol. 2018;141(4):1269–1279.
   PubMed Web of Science ®Google Scholar
• Pham TH, Ren P, Parnes JR, et al. Tezepelumab reduces multiple key inflammatory biomarkers in patients with severe, uncontrolled asthma in the Phase 2b PATHWAY study. Am J Respir Crit Care Med. 2019;199:A2677.
   Web of Science ®Google Scholar
• Sridhar S, Zhao W, Pham T-H, et al. Tezepelumab decreases matrix remodelling and inflammatory pathways in patients with asthma. Eur Respir J. 2019;54(suppl63):RCT3785.
   Google Scholar
• ClinicalTrials.gov. A bronchoprovocation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of CSJ117 in adult subjects with mild atopic asthma. NCT03138811. [ cited 2020 Jan 31]. Available from: https://clinicaltrials.gov/ct2/show/NCT03138811
   Google Scholar
• ClinicalTrials.gov. Study to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma (SOURCE) [cited 2020 Feb 14]. Available from: https://clinicaltrials.gov/ct2/show/NCT03406078
   Google Scholar
• ClinicalTrials.gov. Study to evaluate tezepelumab in adults and adolescents with severe uncontrolled asthma (NAVIGATOR) [cited 2020 Feb 14]. Available from: https://clinicaltrials.gov/ct2/show/NCT03347279
   Google Scholar
• ClinicalTrials.gov. Study to evaluate tezepelumab on airway inflammation in adults with uncontrolled asthma (CASCADE) [cited 2020 Feb 14]. Available from: https://clinicaltrials.gov/ct2/show/NCT03688074
   Google Scholar
• ClinicalTrials.gov. Extension study to evaluate the safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma (DESTINATION) [cited 2020 Feb 14]. Available from: https://clinicaltrials.gov/ct2/show/NCT03706079
   Google Scholar
• Nagarkar DR, Poposki JA, Tan BK, et al. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2013;132(3):593–600 e512.
   PubMed Web of Science ®Google Scholar
• Poposki JA, Klingler AI, Stevens WW, et al. Proprotein convertases generate a highly functional heterodimeric form of thymic stromal lymphopoietin in humans. J Allergy Clin Immunol. 2017;139(5):1559–1567 e1558.
   PubMed Web of Science ®Google Scholar
• Harada M, Hirota T, Jodo AI, et al. Functional analysis of the thymic stromal lymphopoietin variants in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2009;40(3):368–374.
   PubMed Web of Science ®Google Scholar
• Xie Y, Takai T, Chen X, et al. Long TSLP transcript expression and release of TSLP induced by TLR ligands and cytokines in human keratinocytes. J Dermatol Sci. 2012;66(3):233–237.
   PubMed Web of Science ®Google Scholar
• Verstraete K, Peelman F, Braun H, et al. Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma. Nat Commun. 2017;8:14937.
   PubMed Web of Science ®Google Scholar
• Varricchi G, Pecoraro A, Marone G, et al. Thymic stromal lymphopoietin isoforms, inflammatory disorders, and cancer. Front Immunol. 2018;9:1595.
   PubMed Web of Science ®Google Scholar
• Bjerkan L, Schreurs O, Engen SA, et al. The short form of TSLP is constitutively translated in human keratinocytes and has characteristics of an antimicrobial peptide. Mucosal Immunol. 2015;8(1):49–56.
   PubMed Web of Science ®Google Scholar
• Tsilingiri K, Fornasa G, Rescigno M. Thymic stromal lymphopoietin: to cut a long story short. Cell Mol Gastroenterol Hepatol. 2017;3(2):174–182.
   PubMed Web of Science ®Google Scholar
• Fornasa G, Tsilingiri K, Caprioli F, et al. Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin. J Allergy Clin Immunol. 2015;136(2):413–422.
   PubMed Web of Science ®Google Scholar
• Kuroda Y, Yuki T, Takahashi Y, et al. Long form of thymic stromal lymphopoietin of keratinocytes is induced by protein allergens. J Immunotoxicol. 2017;14(1):178–187.
   PubMed Web of Science ®Google Scholar
• Demehri S, Turkoz A, Manivasagam S, et al. Elevated epidermal thymic stromal lymphopoietin levels establish an antitumor environment in the skin. Cancer Cell. 2012;22(4):494–505.
   PubMed Web of Science ®Google Scholar